# A Retrospective Review of Liver Resection Rate in Metastatic Colorectal Cancer Patients Following Downsizing Treatment With Chemotherapy Plus Cetuximab in Normal UK National Health Service Clinical Practice

> **NCT01460745** · — · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 60 (actual)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01460745
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2014-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01460745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01460745, "A Retrospective Review of Liver Resection Rate in Metastatic Colorectal Cancer Patients Following Downsizing Treatment With Chemotherapy Plus Cetuximab in Normal UK National Health Service Clinical Practice". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01460745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*